Sign In
Home
About Us
Benefits
Pricing
Krixos Global Intel
Krixos
Contact Us
Breaking Cancer News A-Z
Health/Pharma Companies
Drugs, Treatments, Trials
Hot Topics
Clinical Trials - Latest News
Other Illnesses & Conditions
Latest Healthcare News
My Settings
Client Requests
Advanced Search
My Viewed Articles
All Cancer News
Acute Lymphoblastic Leukemia
Acute myeloid leukemia
Adenocarcinoma
Adenoid Cystic Carcinoma
Adrenocortical Carcinoma
Anal Cancer
Anaplastic Astrocytoma
Angiosarcoma
Astrocytoma
Basal-Cell Carcinoma
Bladder Cancer
Brain Cancer
Breast Cancer
Cancer Cachexia
Carcinoma
Cervical Cancer
Childhood Cancer
Cholangiocarcinoma
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Adenocarcinoma
Colorectal Cancer
Craniopharyngioma
Endometrial Cancer
Ependymoma
Esophageal Cancer
Ewing's Sarcoma
Gallbladder Cancer
Germ Cell Tumors
Glioblastoma
Glioma
Hairy Cell Leukemia
Hepatocellular Carcinoma
Hodgkin Lymphoma
Kaposi's Sarcoma
Kidney & Renal Cancer
Laryngeal Cancer
Leukemia
Liver Cancer
Lung Adenocarcinoma
Lung Cancer
Lymphoma
Mantle Cell Lymphoma
MCRPC
Medulloblastoma
Melanoma
Meningioma
Mesothelioma
Metastatic Colon Cancer
Mouth Cancer
Multiple Myeloma
Myelodysplastic Syndrome
Myelofibrosis
Nasopharyngeal Carcinoma
Neuroblastoma
NMIBC
Non-Hodgkin Lymphoma
NSCLC
Oral Cancer
Oropharyngeal Cancer
Osteosarcoma
Ovarian Cancer
Pancreatic Adenocarcinoma
Pancreatic Cancer
Pancreatic Neuroendocrine Tumors
Penile Cancer
Pheochromocytoma
Prostate Cancer
Retinoblastoma
Rhabdomyosarcoma
Sarcoma
Sarcopenia
Skin Cancer
Small Cell Lung Cancer
Squamous Cell Carcinoma
Stomach (Gastric) Cancer
Synovial Sarcoma
Testicular Cancer
Thymic Carcinoma
Thymoma
Thyroid Cancer
Tongue Cancer
Uterine Cancer
Vulvar Cancer
Waldenstrom Macroglobulinemia
You need to login...
Enter your email:
Enter your password:
If you are not registered...
Subscribe to Krixos Health:
Sign Up Now:
Your email:
or call us on: +43 (0)1 27 63 015
or email:
subscribe@krixos.com
Most viewed
1.
Global rise in many early-onset GI cancers, with colorectal cancer leading the trend
2.
Complementary detection strategies for circulating tumor cells in breast cancer: clinical implications of combining immunofluorescence and cytopathological staining
3.
European Commission approves Roche's Itovebi for people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutation
4.
Exploring microRNA targeting as a promising approach for solid tumor treatment
5.
Case Report: A novel t(15;17)(q24;q11.2) translocation involving NF1::SCAMP5 fusion in a patient with myeloproliferative neoplasms
6.
Stevia leaf extract has potential as anticancer treatment, researchers find
7.
Researchers discover link between metabolism and protective effect of breastfeeding against breast cancer
8.
Breast cancer test predicts relapse risk in just two weeks – and could spare thousands of patients from unnecessary treatment
9.
Cooler Heads Secures Series A Funding to Revolutionize Scalp Cooling Technology for Chemotherapy Patients
10.
Study: Powerlifting through breast cancer – how a breast cancer survivor defied chemotherapy with strength trainin
Last updated at 12:48 GMT
Hot News Makers
Health/Pharma Companies
Sartorius
131775.30
Abivax
15233.85
Coriolis Pharma
9722.73
Johnson & Johnson
7110.75
Boehringer Ingelheim
5686.96
AbCellera
4459.29
Paul Ehrlich Institute
3562.62
ClinicalTrials.gov
3464.98
Janssen Research
3428.84
PCORI
3313.59
Drugs, Treatments, Trials
Doxorubicin
28507.40
Bamlanivimab
17558.96
Bevacizumab
14769.35
Cyclophosphamide
14700.63
Triamcinolone
13732.40
Pembrolizumab
13650.20
Nivolumab
7648.71
Epirubicin
7285.92
Atezolizumab
4920.53
Tramadol
4813.26
Last updated at 12:10 GMT